8】报告题目：东南亚药食同源产品研究欧美市场开拓发展

                                                                第二届食药物质健康中国国际高峰论坛

                                                                 暨"菩惠宁"癌瘤非药物干预产品功效认证新闻发布会

                                                             东洋应用医学技术有限责任公司（越南）董事长 刘汉存

摘   要：全球大健康产业快速发展 植物类健康产品

关键词：热带草本植物资源储量大天然属性强、功能性突出

论   述：随着全球大健康产业快速发展，天然、绿色、功能性植物类健康产品已成为欧美消费主流。东南亚地区生物资源丰富，拥有悠久的姜黄、诺丽果、高良姜等热带草本植物，药食同源资源储量大、天然属性强、功能性突出，契合欧美市场天然健康、抗炎抗衰、肠道调理、免疫提升的消费需求。当前东南亚药食同源产品正处于产业升级与出海扩张的关键阶段，但在进入欧美市场过程中，仍面临法规壁垒、标准缺失、认知不足、品牌薄弱、产业链不完善等多重难题。东南亚地处热带季风气候区，光照充足、雨量充沛，生物多样性位居全球前列，是亚洲重要的药食同源原料主产区。泰国、印尼、马来西亚、越南等国传承千年草本食疗文化，形成了天然、温和、安全的民间食养体系，广泛应用于抗炎调理、肠胃养护、代谢调节、日常养生等领域。其产品天然无污染、草本活性高、适配现代慢病非药物干预需求，具备极强的国际化发展潜力。欧美是全球最大的功能性食品与植物健康消费市场。近年来，欧美消费者对化学添加剂、合成保健品接受度持续下降，更加青睐有机、溯源清晰、科学实证的天然植物产品。慢性炎症、肥胖、亚健康、免疫力低下等普遍性健康问题，促使市场对草本抗炎、天然抗氧化、肠道微生态调节类产品需求持续攀升。

东南亚特色药食同源原料的功能属性与欧美主流健康消费趋势高度契合，市场空间广阔、增长动能强劲。

总结:东南亚药食同源产品开拓欧美市场面临诸多困境欧美准入法规严苛，合规门槛高。美国 FDA 膳食补充剂备案制度、欧盟新食品认证、安全评估体系极为严格，对新原料、新工艺、产品标签、生产规范均有明确限制。东南亚多数企业生产标准化不足，缺乏国际认证资质，新原料科学数据储备薄弱，难以快速满足欧美市场准入要求。未来，随着国际化合规体系完善、产品科学化升级、品牌影响力提升，东南亚药食同源产业将深度融入全球健康产业链，在欧美功能性食品、天然保健品、慢病非药物干预市场占据稳定份额，极有可能成为全球天然植物赋能全球健康产业的重要增长极。

8】Report topic:Southeast Asian medicinal food products of the same origin research to develop the European and

American markets

The 2nd China International Summit Forum on Food and Drug Quality Health

Press conference on efficacy certification of "Puhuining" cancer tumour non-drug intervention products Dongyang Applied Medical Technology Co., Ltd. (Vietnam) Chairman Hancun Liu

Abstract：Rapid development of the global health industry Plant-based health products

Keyword：Tropical herbaceous plant resource reserves are large, with strong natural properties and outstanding functionality.

Expound：With the rapid development of the global health industry, natural, green and   products have become the mainstream of European and American consumption. Southeast Asia is rich in biological resources, with long-standing tropical herbs such as turmeric, noli fruit and Gaoliang ginger. It has large reserves of resources of the same origin as medicinal food, strong natural properties and outstanding functionality, which meets the consumption needs of natural health, anti-inflammatory and anti-ageing, intestinal conditioning and immune improvement in the European and American markets. At present, Southeast Asian medicinal and food products of thesame origin are in a critical stage of industrial upgrading and overseas expansion, but in the process of entering the European and American markets, they still face multiple problems such as regulatory barriers, lack of standards,

insufficient recognition, weak brand, and imperfect industrial chain.Southeast Asia is located in the tropical monsoon

climate zone, with sufficient sunlight and abundant rainfall, and biodiversity ranks among the forefront of the world. It is an important main production area of raw materials of medicinal food and cogenous origin in Asia. Thailand,

Indonesia, Malaysia, Vietnam and other countries have inherited the culture of herbal diet therapy for thousands of years, forming a natural, mild and safe folk diet system, which is widely used in anti-inflammatory conditioning,

gastrointestinal maintenance, metabolic regulation, daily health care and other fields. Its products are natural and pollution-free, with high herbal activity, suitable for the needs of non-drug intervention in modern chronic diseases,

and have strong potential for international development. Europe and the United States are the world's largest consumer markets for functional food and plant health.In recent years, consumers in Europe and the United States have continued to decline in their acceptance of chemical additives and synthetic health care products, and they prefer organic, clearly traceable and scientifically verified natural plant products. Chronic inflammation, obesity, sub-health,

low immunity and other common health problems have promoted the market demand for herbal anti-inflammatory,

natural antioxidant and intestinal micro-ecological regulation products to continue to rise. The functional attributes of Southeast Asian characteristic medicinal food raw materials of the same origin are highly compatible with the mainstream health consumption trend in Europe and the United States, with a wide market space and strong growth momentum.

Conclusion：Southeast Asian medicinal and food products of the same origin face many difficulties in developing the European and American markets. European and American access regulations are strict, and the compliance threshold is high. The U.S. FDA dietary supplement filing system, the EU's new food certification and safety assessment system are extremely strict, and there are clear restrictions on new raw materials, new processes, product labels and production

specifications. Most enterprises in Southeast Asia have insufficient production standardisation, lack of international certification qualifications, and weak scientific data reserve of new raw materials, which makes it difficult to quickly meet the requirements of European and American market access. In the future, with the improvement of the international compliance system, the scientific upgrading of products, and the improvement of brand influence, the Southeast Asian medicinal food industry will be deeply integrated into the global health industry chain, occupying a stable share in the European and American functional food, natural health care products, and non-drug intervention markets for chronic diseases, and is very likely to become the global natural plants to empower the world. An important growth pole in the health industry

编辑：食药物质国际交流栏目组  愚晏

翻译：国际食药物质与健康产业联盟 执行秘书长 孙丽

校对：国际疾病非药物干预科学应用联盟（中国代表处）执行秘书长 吴玲